About GTC Steve Winwood BiotherapeuticsGTC Biotherapeutics develops

About GTC exhibits arc of a diver steve winwood BiotherapeuticsGTC Biotherapeutics winwood chords recounts develops, supplies, and commercializes therapeutic proteinsproduced through transgenic animal technology. In addition to ATryn, GTC isdeveloping a portfolio of recombinant human plasma proteins with knowntherapeutic properties. These proteins include recombinant forms of humancoagulation factors VIIa, VIII, and IX, which are used for the treatment ofhemophilia, and alpha-1 antitrypsin. GTC also has a monoclonal antibodyportfolio that includes a monoclonal antibody to CD20 and a monoclonal antibodyto CD137. GTC`s intellectual property includes a patent in the United Statesthrough 2021 for the production of any therapeutic protein in the milk of anytransgenic mammal.

GTC`s transgenic production platform is particularly wellsuited to enabling cost effective development of proteins that are difficult toexpress in traditional recombinant production systems as well as proteins thatare required in large volumes back in the high life again steve winwood . Additional information is available on the GTCweb site, This press release contains forward-looking statements as defined in the PrivateSecurities Litigation Reform Act of 1995, including without limitationstatements regarding the timing of the FDA`s review of the BLA for ATryn winwood discography . Suchforward-looking statements are subject to a number of risks, uncertainties andother factors that could cause actual results to differ materially from futureresults expressed or implied by such statements lyrics winwood . Factors that may cause suchdifferences include, but are not limited to, the risks and uncertaintiesdiscussed in GTC's most recent Annual Report on Form 10-K and its other periodicreports filed with the Securities and Exchange Commission, including theuncertainties associated with dependence upon the actions of regulatoryagencies winwood capaldi . GTC cautions investors not to place undue reliance on the forward-lookingstatements contained in this release.

These statements speak only as of the dateof this document, and GTC undertakes no obligation to update or revise thestatements, except as may be required by law back in the high life steve winwood . About OVATION PharmaceuticalsOVATION is a fast growing biopharmaceutical company that develops andcommercializes medically necessary therapies to satisfy unmet medical needs forpatients with severe illnesses winwood valerie . Headquartered in Deerfield, Ill., with productsavailable in more than 85 countries, OVATION is committed to having asignificant impact on patients` lives through its focus on central nervoussystem (CNS), hematology/oncology, and hospital-based therapies steve rock . The three newlaunches the company expects over the next three years will be fueled largely byits late-stage CNS pipeline, which is one of the most robust in the industry.OVATION has been recognized for excellence in the global pharmaceutical andbiotechnology industries with the 2006 and 2007 "Pharma Company of the Year"award from Scrip magazine for small to mid-sized enterprises winwood music . More informationabout the company, its products and full prescribing information may be found at * ATryn is a registered trademark of GTC Biotherapeutics GTC Biotherapeutics, Inc.Thomas E.

Newberry, 508-370-5374Vice President, Corporate Communications and Government orOVATION Pharmaceuticals, Inc.Sally Benjamin Young, 847-727-3265Vice President of Copyright Business Wire 2009 best of steve winwood . NEW YORK (Reuters) - These days, American Express Co (AXP.N) and Discover Financial Services (DFS.N) are sitting on billions of dollars of legal settlements and taxpayer dollars eric winwood . Crisis in CreditBut for the two credit card giants, weaning themselves from short-term borrowing -- which has proved unreliable lately -- may force them to spend heavily in the short term.By loosening up purse strings and paying upfront to acquire a bank, or multiple banks, the credit card companies could ensure more stable long-term funding for themselves in the form of bank deposits, analysts said."Both AmEx and Discover are probably thinking long and hard whether they might want to buy a bank," said James Ellman, president of hedge fund Seacliff Capital.But even if money is not a problem, both have said buying a bank is not a priority.American Express got $1.8 billion last year when it settled a case against MasterCard Inc (MA.N) alleging antitrust practices, while Discover is receiving $2.75 billion from Visa Inc (V.N) and MasterCard in a similar settlement.In addition, American Express -- which sold its international banking operation in 2007 to focus on the credit card business -- recently became a bank holding company and is expected to get $3.39 billion from the government.Discover has applied to get bank status, too, and expects to receive up to $1.2 billion.And prices might never be better The credit crisis crushed the value of most U.S steve band . banks, sending the KBW Banks Index .BKX down some 55 percent in 2008, making acquisitions attractive and affordable.Regional banks Huntington Bancshares Inc (HBAN.O), Regions Financial Corp (RF.N), Synovus Financial Corp (SNV.N), Comerica Inc (CMA.N) and Keycorp (KEY.N) -- with market capitalizations between $2 billion and $5 billion -- have become likely targets, a hedge fund manager who requested anonymity said.The five banks declined to comment.BUT ARE THEY BUYERS?Both American Express and Discover -- which have relied on capital markets to cover their funding needs -- have said buying a bank is not at the top of their list.But now, analysts wonder if they will follow rival Capital One Financial Corp (COF.N), which turned out to be prescient in transforming itself into a bank through the purchase of Hibernia in 2005 and North Fork Bank in 2006."My sense is that's the direction they are headed," said Mark Kanaly, a financial services partner at the law firm Alston & Bird.Any major concerns about funding for operations were eased by obtaining the bank holding company status, which guaranteed access to the Federal Reserve discount window if quick financing is required, analysts said.But even with that, they are at a disadvantage versus rivals JPMorgan Chase & Co (JPM.N), Citigroup Inc (C.N) and Bank of America Corp (BAC.N), which have a wider access to funding steve traffic . A bank acquisition could narrow the gap.Possible strategies could include buying a medium-sized institution and using it as a springboard for further acquisitions, Kanaly said."I would not rule (an acquisition) out," David Nelms, chief executive of Discover, told Reuters last month, although he added it was not a priority.An American Express spokeswoman also said running a branch network was not a priority. The company easily met its debt requirements for the fourth quarter and feels comfortable with its funding outlook, she added.Both have said they would use the taxpayer money to expand credit.SO, WHY NOT?The risk of buying a bank is that with deposits come bad debts and the banks that offer the deepest discounts could also bring a bulk of losses.A risky deal could also add further pressure on the shares of American Express and Discover, which lost 60 and 36 percent respectively in the last year.The best option would be to buy the deposit base of a failed bank, leaving the risk of toxic assets to the U.S government, Ellman said.

Twenty-five banks failed in 2008 and more are expected to go this year.The urgency to buy a bank would depend on whether or not the credit crisis worsens, but with the $1 trillion credit card industry facing record credit losses of around $70 billion in 2009 -- as unemployment rises to the highest level since the early 1980s -- the outlook is gloomy."These two institutions really cannot stand alone from the rest of the credit card industry and they are the only two that are not part of a larger, more diversified banking institution," said John Bartko, an analyst at credit rating agency Standard & Poor's.S&P cut American Express' rating to "A" last month due to increasing financial pressure on the industry The outlook is negative, suggesting more cuts may come . While Discover's outlook is stable, it has a "BBB-" rating, the last step of the investment grade category.(Additional reporting by Dan Wilchins and Paritosh Bansal; Editing by Andre Grenon) Crisis in Credit steve valerie . Theo Epstein said: "If we can't [sign Jason Bay], we have to get creative in left field winwood stevie . It could mean a big-money guy; it could mean a couple of lesser investments"Lets put two and two together:  1 The Sox havent signed Jason Bay  2 . The Sox have made a trade for Jeremy Hermida, a cheap outfielder who has yet to produce at the big leage level but has a tremendous upside.Why is it that Im the only person in Red Sox Nation who thinks Jeremy Hermida is the replacement for Jason Bay? Isnt it obvious.......read more. National Business Aviation Association (NBAA) President & CEO Ed BolenAvailable for CommentWhat: NBAA is available as a resource to highlight the unintendedconsequences of a provision in a proposed amendment to the Troubled AssetsRelief Program (TARP), introduced Friday, which would ban use of businessaircraft by companies taking part in the program.Who: Ed Bolen, NBAA President and CEO.*Enactment of the provision will put the jobs of tens of thousands ofhard-working Americans at risk.